By using ARE reporter plasmids, miR-432-3p was supposed to promote the NRF2 protein stabilization by directly binding the KEAP1 coding region, thus increasing the resistance of cancer cells to cisplatin (CDDP) [100]. Here, NFE2L2 is linked to cancer.